Document is current
Any future updates will be listed below
-
Authors
Tarimo, Edith A.M
Iseselo, Masunga K.
Ambikile, Joel S.
Lukumay, Gift
Munseri, Patricia
Bakari, Muhammad
Lyamuya, Eligius
Aboud, Said
Kawuma, Rachel
Seeley, Janet
,
-
Funding
Funding for this research was provided by:
Gilead (CO-UK-412-5430)
- License Information
-
More Information
Article History
Received: 16 March 2025
Accepted: 28 July 2025
First Online: 25 August 2025
Declarations
:
: The PrEPVacc study received ethical approval from the National Ethics Committee in Tanzania (Approval number: NIMR/HQ/R.8a/Vol.IX/3333) and from the Muhimbili University of Health and Allied Sciences (Approval number: MUHAS-REC-11-2019-066), and it was conducted per the Declaration of Helsinki. Before commencement of data collection, the interviewer and the participants revisited the study information shared at previous visits to ensure the participants still recall what the qualitative study is about. They were assured of the confidentiality that even the clinic team would not get to know what they shared, unless with their permission. Clarification was made for anything they did not understand, and they were answered any question they had. When the interviewer was satisfied that the information has been understood and the participant(s) was in agreement, the participant was given two copies (one for the study and another one for the participant) of informed consent to sign and date. The participants in FGDs were taken through the same process in groups. In addition, the participants were requested that the interview would be audio-recorded, and the audios would be transcribed without disclosing their personal information. This anonymity was ensured by giving each participant a number from the start of IDI of FGD. Thus, written informed consent was obtained from all the potential study participants. The participants were assured of their freedom to participate or withdraw from the study at any time and that by doing so, they would not compromise the services they were entitled to during the study. Also all the participants were assured of their privacy. They were informed that the knowledge generated from the shared information will be disseminated in various forums anonymously without disclosing their personal identification. All the participants received transport compensation in 30,000 Tanzanian Shillings equivalent to $12 US Dollars. Also, the participants were reminded about available referral services if they needed health care or other support.
: Not applicable.
: The authors declare no competing interests.
